Back
Lendway, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
42
LDWY
Lendway, Inc.
Last Price:
$3.47
Seasonality Move:
12.82%
Sell
41
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.09
Seasonality Move:
25.93%
Sell
42
Lendway, Inc. (LDWY)
is a Sell
Is Lendway, Inc. a Buy, Sell or Hold?
-
The current Lendway, Inc. [LDWY] share price is $3.52. The Score for LDWY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
LDWY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $70.50. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LDWY Stock Price Chart
What is Lendway, Inc.'s stock price today?
-
The Lendway, Inc. share price today is $3.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDWY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $70.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
LDWY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 45.85 | Sell |
| Chaikin Money Flow: | 35699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.4 - 3.7) | Sell |
| Bollinger Bands (100): | (3.87 - 5.33) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.48 | Sell |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | -194871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.3 - 85.58) | Sell |
| Bollinger Bands (100): | (46.5 - 89.48) | Buy |
LDWY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.39 | Buy |
| 20-day SMA: | 3.55 | Sell |
| 50-day SMA: | 4.03 | Sell |
| 200-day SMA: | 4.52 | Sell |
| 8-day EMA: | 3.44 | Buy |
| 20-day EMA: | 3.56 | Sell |
| 50-day EMA: | 3.94 | Sell |
| 200-day EMA: | 4.45 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.62 | Sell |
| 20-day SMA: | 76.51 | Sell |
| 50-day SMA: | 80.5 | Sell |
| 200-day SMA: | 52.75 | Buy |
| 8-day EMA: | 71.14 | Sell |
| 20-day EMA: | 74.96 | Sell |
| 50-day EMA: | 76.33 | Sell |
| 200-day EMA: | 56.96 | Buy |
Lendway, Inc. Earnings Growth & LDWY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Lendway, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||